FeeBase
Log inGet started
Menu

HCPCS code Q5107: Mvasi injection, per 10 mg2026 Medicare rate & RVUs

Reports bevacizumab-awwb (Mvasi), an intravenous biosimilar used in oncology treatment, in 10 mg units for the drug administered during a treatment regimen.

CMS RVU26DEffective Oct 1, 2026109 payment localities

Medicare rate · Q5107

Mvasi injection, per 10 mg

Office or facility?

Work RVUs
0
Total RVUs
0.00
Global days
XXX

National rate · 2026

—

Not priced in the facility setting.

See every locality for Q5107 →Billed by an NP, PA or therapist? →

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

Your location

Medicare pays by the payment locality where the service is performed.

On this page 10 sections
  1. Medicare rate
  2. What Q5107 covers
  3. By payment locality
  4. Rate map
  5. How it’s calculated
  6. Payment rules
  7. Similar codes
  8. Related codes
  9. Billing questions
  10. Sources

What Q5107 covers

Bevacizumab-awwb (Mvasi) is an intravenous biosimilar medicine used in oncology treatment. Oncology practices and hospital infusion departments report Q5107 for the drug administered as part of a treatment regimen. This HCPCS Level II code identifies the medication rather than the infusion administration service; report the applicable administration service separately when performed.

Each unit represents 10 mg, so calculate units by dividing the administered dose in milligrams by 10. CMS assigns physician fee schedule status E, excluding the drug from that schedule. When Medicare covers the item, payment is made under another method; CMS identifies it as a Part B drug generally priced using quarterly Average Sales Price files. Special Medicare coverage instructions apply.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where Q5107 pays more and less

The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.

109 of 109 payment localities

Q5107 office and facility rates by payment locality
Payment localityOfficeFacility
AlabamaUnavailableUnavailable
AlaskaUnavailableUnavailable
ArizonaUnavailableUnavailable
ArkansasUnavailableUnavailable
Atlanta, GAUnavailableUnavailable
Austin, TXUnavailableUnavailable
Bakersfield, CAUnavailableUnavailable
Baltimore area, MDUnavailableUnavailable
Beaumont, TXUnavailableUnavailable
Brazoria, TXUnavailableUnavailable

Q5107 rates by state

Office rate range in each state. Select a state to see its payment localities.

MEWIVTNHMTNDMNMINYMARIWAIDWYSDIAILINOHPANJCTORNVUTCONEMOKYWVVAMDDECAAZNMKSOKARTNNCSCDCTXLAMSALGAFLAKHI

Explore a state

Local rates. Clear comparisons.

Hover or focus a tile to see its rate range. Select it to open the state’s fee schedule.

View every state and territory as a table
Q5107 office rate range by state
State / territoryOffice rate rangeLocalities
AKNo published base rate1
ALNo published base rate1
ARNo published base rate1
AZNo published base rate1
CANo published base rate29
CONo published base rate1
CTNo published base rate1
DCNo published base rate1
DENo published base rate1
FLNo published base rate3
GANo published base rate2
GUNo published base rate1
HINo published base rate1
IANo published base rate1
IDNo published base rate1
ILNo published base rate4
INNo published base rate1
KSNo published base rate1
KYNo published base rate1
LANo published base rate2
MANo published base rate2
MDNo published base rate3
MENo published base rate2
MINo published base rate2
MNNo published base rate1
MONo published base rate3
MSNo published base rate1
MTNo published base rate1
NCNo published base rate1
NDNo published base rate1
NENo published base rate1
NHNo published base rate1
NJNo published base rate2
NMNo published base rate1
NVNo published base rate1
NYNo published base rate5
OHNo published base rate1
OKNo published base rate1
ORNo published base rate2
PANo published base rate2
PRNo published base rate1
RINo published base rate1
SCNo published base rate1
SDNo published base rate1
TNNo published base rate1
TXNo published base rate8
UTNo published base rate1
VANo published base rate2
VINo published base rate1
VTNo published base rate1
WANo published base rate2
WINo published base rate1
WVNo published base rate1
WYNo published base rate1

How the Q5107 rate is calculated

Each of Q5107’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

How the rate is built · Q5107

RVUs × geographic indexes × conversion factor

Office or facility?

Work0.00

0.00 RVUs× 1.000 GPCI

Practice expense0.00

0.00 RVUs× 1.000 GPCI

Malpractice0.00

0.00 RVUs× 1.000 GPCI

Adjusted RVUs

0.0000

Conversion factor

$33.4009

Medicare rate

$0.00

Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.

Payment rules and modifiers for Q5107

Q5107 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

Place of service · Q5107

Which rate does Medicare pay?

The POS code on the claim line (CMS-1500 box 24B).

POS 11 · non-facility rate · national

—

Q5107 isn’t priced in this setting.

Q5107 compared with similar codes

Compare codes · National

4 codes, side by side

Office or facility?

  • Q5107

    Mvasi injection, per 10 mg0 wRVU

    Not priced

  • Q5118

    Zirabev injection, per 10 mg0 wRVU

    Not priced

  • Q5126

    Alymsys injection, per 10 mg0 wRVU

    Not priced

  • J9035

    Bevacizumab, per 10 mg0 wRVU

    Not priced

How to choose

Q5118Zirabev injectionPer 10 mg
Use Q5118 for bevacizumab-bvzr (Zirabev); Q5107 is specific to bevacizumab-awwb (Mvasi). Both represent 10 mg units.
Q5126Alymsys injectionPer 10 mg
Q5126 identifies bevacizumab-maly (Alymsys). Select between it and Q5107 according to which product was administered.
J9035BevacizumabPer 10 mg
J9035 identifies bevacizumab, while Q5107 identifies the bevacizumab-awwb biosimilar. Match the reported code to the product administered.

Codes related to Q5107

Related codes aren’t interchangeable: bill the code that matches the service performed.

Codes related to Q5107
CodeHow it relatesNational office range
Used instead
Q5118Zirabev injection, per 10 mgIdentifies bevacizumab-bvzr (Zirabev), a different bevacizumab biosimilar product.No office rate
Q5126Alymsys injection, per 10 mgIdentifies bevacizumab-maly (Alymsys), a different bevacizumab biosimilar product.No office rate
J9035Bevacizumab, per 10 mgIdentifies bevacizumab rather than the bevacizumab-awwb biosimilar.No office rate

Q5107 billing questions

What does one unit of Q5107 represent?

One unit represents 10 mg of bevacizumab-awwb. Calculate units from the administered dose in 10 mg increments.

How is Q5107 different from Q5118?

Q5107 identifies bevacizumab-awwb (Mvasi), while Q5118 identifies bevacizumab-bvzr (Zirabev). Select the code for the specific product administered.

Is the infusion administration service included in Q5107?

Q5107 identifies the drug rather than the administration service. Report the applicable administration service separately when performed.

Does Medicare pay Q5107 under the physician fee schedule?

CMS assigns status E, excluding the drug from the physician fee schedule. When Medicare covers it, payment is handled through another method; Part B drug pricing generally uses quarterly ASP files.

What should the medical record support?

Document the product administered and the dose so the reported 10 mg units can be substantiated.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates

Did this answer your question about what Q5107 pays?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put Q5107 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist